Prezista Alternatives Compared
Prezista (darunavir) | Bictegravir / emtricitabine / tenofovir alafenamide | Cabenuva (cabotegravir / rilpivirine) |
|
---|
Prezista (darunavir) | Bictegravir / emtricitabine / tenofovir alafenamide | Cabenuva (cabotegravir / rilpivirine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for HIV Infection. Prezista may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for HIV Infection. Cabenuva may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Prezista (darunavir) | More about Bictegravir / emtricitabine / tenofovir alafenamide | More about Cabenuva (cabotegravir / rilpivirine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Prezista has an average rating of 7.7 out of 10 from a total of 4 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.2 out of 10 from a total of 216 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 19% reported a negative effect. |
Cabenuva has an average rating of 8.0 out of 10 from a total of 22 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Bictegravir / emtricitabine / tenofovir alafenamide side effects |
||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Prezista prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cabenuva prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Biktarvy |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
15 hours |
180 hours |
50 hours (empirically) |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 518 drugs are known to interact with Prezista:
|
A total of 435 drugs are known to interact with Bictegravir / emtricitabine / tenofovir alafenamide:
|
A total of 451 drugs are known to interact with Cabenuva:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
June 23, 2006 |
February 07, 2018 |
January 21, 2021 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.